Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Trichoscopy is a good, quick, non-invasive way to diagnose different types of hair loss.

More research is needed to understand hair and scalp disorders in people with skin of color.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Raising awareness about PCOS can improve women's quality of life.

Combining minoxidil with microneedling or spironolactone is more effective for female hair loss than using minoxidil alone.

Temporal hair loss relates to overall scalp hair loss in women.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

Gut flora changes could potentially indicate depression, but more research is needed.

Minoxidil 2% is more effective for female hair loss, but botanicals have fewer side effects.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Adult female acne is complex and requires a combination of treatments for effective management.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.